CLINICAL_TRIALS
trial_result
· 2013-10-10
Clinical Trial Update: Phase II Trial of Oxaliplatin in Combination With S-1(SOX) in Patients With Recurrent or Metastatic Breast Cancer [Phase 2]
Summary
Completed Phase II clinical trial evaluating oxaliplatin in combination with S-1 (SOX) for recurrent or metastatic breast cancer.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Seoul National University Hospital | Conditions: Breast Neoplasms | Phase 2 | Status: COMPLETED